RADCOM RDCM 深 沪
交易中 08-21 09:56:18 美东时间
12.70
-0.010
-0.08%
华盛通- 最 高12.70
- 今 开12.70
- 成交量 1551股
- 最 低 12.70
- 昨 收 12.71
- 总市值 2.04亿
- 52周最高 15.98
- 市盈率 静 29.45
- 换手率 0.01%
- 52周最低 9.23
- 委 比 43.82%
- 总股本 1602.93万
- 历史最高 22.45
- 量 比 0.78
- 振 幅 0.00%
- 历史最低 2.08
- 每 手 1
- 风险率 0.99%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Radcom Affirms FY2025 Sales Guidance of $71.100M vs $70.632M Est
Radcom (NASDAQ:RDCM) affirms FY2025 sales outlook from $71.100 million to $71.100 million vs $70.632 million estimate.
08-13 19:14
Radcom Q2 Adj. EPS $0.25 Beats $0.23 Estimate, Sales $17.70M Beat $17.05M Estimate
Radcom (NASDAQ:RDCM) reported quarterly earnings of $0.25 per share which beat the analyst consensus estimate of $0.23 by 11.11 percent. This is a 25 percent increase over earnings of $0.20 per share from the same period
08-13 19:10
Earnings Scheduled For August 13, 2025
Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...
08-13 16:32
Under the Radar: Low Coverage. Low Ownership. High Upside?
I refer to Peter Lynch fairly often in my conversation about stock picking. The...
08-06 00:30
美股大行评级 | 潜在涨幅1281.22%！Cabaletta Bio获Guggenheim升目标价至25美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1130057143861719040.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Guggenheim：维持Cabaletta Bio(CABA)"买入"评级，目标价从23美元升至25美元</p> <p>• 瑞穗：维持Tectonic Therapeutic(TECX)"跑赢大市"评级，目标价从51美元
05-16 08:43
Needham Maintains Buy on Radcom, Raises Price Target to $18
Needham analyst Ryan Koontz maintains Radcom (NASDAQ:RDCM) with a Buy and raises the price target from $17 to $18.
05-15 18:41
Radcom shares are trading higher after the company reported better-than-expected Q1 adjusted EPS results and raised its FY25 sales guidance above estimates.
Radcom shares are trading higher after the company reported better-than-expecte...
05-14 20:03
Radcom Raises FY2025 Sales Guidance from $69.20M to $71.10M vs $68.75M Est
Radcom (NASDAQ:RDCM) raises FY2025 sales outlook from $69.20 million to $71.10 million vs $68.75 million estimate.
05-14 19:09
Earnings Scheduled For May 14, 2025
Companies Reporting Before The Bell • Cellebrite DI (NASDAQ:CLBT) is expected t...
05-14 16:32
William Blair Remains a Buy on Radcom (RDCM)
In a report released today, Arjun Bhatia from William Blair maintained a Buy ra...
02-13 05:15
